Medicines and Healthcare Products Regulatory Agency (Health) [2023] UKICO 166253 (6 March 2023)


BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?

No donation is too small. If every visitor before 31 December gives just £1, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!



BAILII [Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback]

Information Commissioner's Office
You are here: BAILII >> Databases >> Information Commissioner's Office >> Medicines and Healthcare Products Regulatory Agency (Health) [2023] UKICO 166253 (6 March 2023)
URL: http://www.bailii.org/uk/cases/UKICO/2023/166253.html
Cite as: [2023] UKICO 166253

[New search] [Printable PDF version] [Help]

Medicines and Healthcare Products Regulatory Agency

The complainant has submitted multiple requests for information to Medicines and Healthcare Products Regulatory Agency (“MHRA”) about Pfizer drugs. The Commissioner’s decision is that MHRA has not demonstrated that complying with the request would impose a grossly oppressive burden and consequently it is not entitled to rely on section 14(1). The Commissioner requires MHRA to respond to the request again, without relying upon section 14(1) of FOIA. MHRA must take these steps within 35 calendar days of the date of this decision notice. Failure to comply may result in the Commissioner making written certification of this fact to the High Court pursuant to section 54 of FOIA and may be dealt with as a contempt of court.

FOI 14: Complaint upheld

Decision notice: 166253

BAILII: Copyright Policy | Disclaimers | Privacy Policy | Feedback | Donate to BAILII
URL: http://www.bailii.org/uk/cases/UKICO/2023/166253.html